The global recombinant vaccine market is anticipated to grow at a CAGR of 3.36% during the forecast period. The key companies operating in the industry are highly inclined towards the adoption of different growth strategies including capacity expansion, partnerships, mergers, and acquisitions, geographical expansions, and product innovations to remain competitive in the market. For instance, in July 2020, Sanofi and GlaxoSmithKline have collaborated with the U.S Government to supply 100 million doses of their COVID-19 recombinant protein-based vaccine. This collaboration aimed to meet the government’s Operation Warp Speed Goal, to ensure the availability of 100 million effective covid-19 vaccine doses in a rapid manner. Moreover, the companies also collaborated with the UK government to supply up to 60 million doses of recombinant protein-based COVID-19 vaccine. Further, the companies also announced the collaboration with global health organizations, businesses, and leaders of governments to speed up the production activities and ensure equitable access to COVID-19 treatments and vaccines
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/recombinant-vaccines-market
Additionally, in May 2021, Bavarian Nordic A/S has partnered with Dynavax Technologies Corp with an intent to commercialize and distribute the Heplisav-b. Heplisav –b is a recombinant hepatitis b vaccine developed by Dynavax Technologies Corp. In February 2021, the European Commission granted the marketing authorization for Heplisav-b for immunization against hepatitis –b virus infection in individuals of 18 years and above. Furthermore, in November 2021, The Phillippine Food and Drug Administration granted an emergency use authorization of recombinant nanoparticle protein-based COVID-19 with Matrix-M adjuvant. The vaccine will be manufactured in the Philippines by the Serum Institute of India (SII) under the brand name COVOVAX. Thus, product launches and key collaborations are anticipated to accelerate the growth of the global recombinant vaccine market during the forecast period.
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
Segment Covered-
- By Type
- By Route of Administration
- By Disease
- By Distribution Channel
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape- GlaxoSmithKline plc, Sanofi S.A., and Novartis International AG, among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected regions and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Recombinant Vaccine Market Report Segment
By Type
- Sunbit Vaccine
- Live Attenuated
By Route of Administration
- Oral
- Parenteral
By Disease
- Human Papilloma Virus
- Hepatitis b
- Rotavirus
- Others
By Distribution Channel
- Hospital and Retail Pharmacies
- Government Supplier
A full report of Recombinant Vaccine Market is available at: https://www.omrglobal.com/industry-reports/recombinant-vaccines-market
Recombinant Vaccine Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Alnylam Pharmaceuticals, Inc.
- AstraZeneca Plc.
- AmbioPharm, Inc.
- Biocon Ltd.
- Daiichi Sankyo Co.
- Dynavax Technologies
- Reddys Laboratories, Ltd.
- Ionis Pharmaceuticals, Inc.
- Johnson & Johnson Services, Inc
- Pfizer Inc.
- Serum Insititute of India Pvt.Ltd
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research